Our results showed an increasing trend of INSTI prescriptions as an anchor drug class and a predominant prescription of TDF comprising approximately two-thirds of backbone prescriptions as the first regimen in recent years.
← all excerpts
Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database.
1
—
—